Predict your next investment

HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year

1987

Stage

Acquired | Acquired

Total Raised

$21M

About Enzytech

Developer of two distinct product lines based on protein stabilization and manipulation technology. The Controlled Therapeutics Division is developing controlled or time-release polymers for use with pharmaceutical compounds. These polymers will reduce the need for multiple injections of specific drugs. The Food Ingredients Division is developing low fat, low calorie, natural food products. All technology is based on naturally occurring compounds rather than chemically-derived compounds. The Food Ingredients Division was spun-off in April 1991 as Opta Food Ingredients, Inc.

Enzytech Headquarter Location

64 Sidney Street

Cambridge, Massachusetts, 02139,

United States

(617)252-0001

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Enzytech Patents

Enzytech has filed 4 patents.

The 3 most popular patent topics include:

  • Psychiatric diagnosis
  • Abnormal psychology
  • Chemical processes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/28/2018

4/16/2019

Psychiatric diagnosis, Metal halides, Chemical processes, Ketones, Phase transitions

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

2/28/2018

00/00/0000

00/00/0000

00/00/0000

Grant Date

4/16/2019

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Psychiatric diagnosis, Metal halides, Chemical processes, Ketones, Phase transitions

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.